comparemela.com

Latest Breaking News On - Ys biopharma - Page 7 : comparemela.com

YS Biopharma (YS) and The Competition Financial Contrast

YS Biopharma (NASDAQ:YS – Get Rating) is one of 719 publicly-traded companies in the “Holding & other investment offices” industry, but how does it compare to its rivals? We will compare YS Biopharma to similar companies based on the strength of its valuation, profitability, risk, earnings, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This […]

YS Biopharma (NASDAQ:YS) Shares Down 4 6%

YS Biopharma Co., Ltd. (NASDAQ:YS – Get Rating)’s stock price was down 4.6% on Thursday . The company traded as low as $1.37 and last traded at $1.44. Approximately 416,423 shares changed hands during mid-day trading, a decline of 47% from the average daily volume of 786,233 shares. The stock had previously closed at $1.51. […]

YS Biopharma s PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study

The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.